BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:75381-75388. [PMID: 29088873 DOI: 10.18632/oncotarget.18856] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Topkan E, Besen AA, Ozdemir Y, Kucuk A, Mertsoylu H, Pehlivan B, Selek U. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide. Mediators Inflamm 2020;2020:4392189. [PMID: 32565725 DOI: 10.1155/2020/4392189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Selcuk M, Cinar T, Saylik F, Dogan S, Selcuk I, Orhan AL. Predictive Value of Systemic Immune Inflammation Index for Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Medeni Med J 2021;36:318-24. [PMID: 34939398 DOI: 10.4274/MMJ.galenos.2021.37998] [Reference Citation Analysis]
3 Abravan A, Salem A, Price G, Faivre-Finn C, van Herk M. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncol 2022;61:163-71. [PMID: 34979860 DOI: 10.1080/0284186X.2021.2022201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fang H, Zhang H, Wang Z, Zhou Z, Li Y, Lu L. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal 2020;34:e23016. [PMID: 31423643 DOI: 10.1002/jcla.23016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
5 Mirili C, Paydas S, Kapukaya TK, Yılmaz A. Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomark Med 2019;13:1565-75. [PMID: 31631675 DOI: 10.2217/bmm-2019-0303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zhang Y, Lin S, Yang X, Wang R, Luo L. Prognostic value of pretreatment systemic immune-inflammation index in patients with gastrointestinal cancers. J Cell Physiol 2019;234:5555-63. [PMID: 30353545 DOI: 10.1002/jcp.27373] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
7 Stühler V, Herrmann L, Rausch S, Stenzl A, Bedke J. Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab. Cancers (Basel) 2022;14:2972. [PMID: 35740636 DOI: 10.3390/cancers14122972] [Reference Citation Analysis]
8 Topuz MF, Ture N, Akdag G, Arik O, Gulhan PY. The importance of systemic immune-inflammation index in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol. [DOI: 10.1007/s00405-021-07227-0] [Reference Citation Analysis]
9 Tosu AR, Kalyoncuoglu M, Biter Hİ, Cakal S, Selcuk M, Çinar T, Belen E, Can MM. Prognostic Value of Systemic Immune-Inflammation Index for Major Adverse Cardiac Events and Mortality in Severe Aortic Stenosis Patients after TAVI. Medicina (Kaunas) 2021;57:588. [PMID: 34201104 DOI: 10.3390/medicina57060588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ruta VM, Man AM, Alexescu TG, Motoc NS, Tarmure S, Ungur RA, Todea DA, Coste SC, Valean D, Pop MC. Neutrophil-To-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease. Medicina (Kaunas) 2020;56:E381. [PMID: 32751302 DOI: 10.3390/medicina56080381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Shoji F, Kozuma Y, Toyokawa G, Yamazaki K, Takeo S. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer. Ann Thorac Cardiovasc Surg 2020;26:248-55. [PMID: 32074540 DOI: 10.5761/atcs.oa.19-00315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Wang Y, Kuo L, Weng H, Hsu C, Tsai M, Chang G, Lee Y, Huang EI, Tsai Y. Systemic Immun e–Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis. Front Oncol 2022;12:899518. [DOI: 10.3389/fonc.2022.899518] [Reference Citation Analysis]
13 Biswas T, Kang KH, Gawdi R, Bajor D, Machtay M, Jindal C, Efird JT. Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int J Environ Res Public Health 2020;17:E7995. [PMID: 33143164 DOI: 10.3390/ijerph17217995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Keskin M, Öcal L, Cerşit S, Yılmaz C, Küp A, Çelik M, Doğan S, Koyuncu A, Kaya A, Turkmen MM. The Predictive Role of a Novel Risk Index in Patients Undergoing Carotid Artery Stenting: Systemic Immune-Inflammation Index. J Stroke Cerebrovasc Dis 2021;30:105955. [PMID: 34242858 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105955] [Reference Citation Analysis]
15 Holtzman L, Moskovitz M, Urban D, Nechushtan H, Keren S, Reinhorn D, Wollner M, Daher S, Rottenberg Y, Rovitzky Y, Shochat T, Bar J, Dudnik E. dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%. Clinical Lung Cancer 2021. [DOI: 10.1016/j.cllc.2021.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kucuk A, Ozkan EE, Eskici Oztep S, Mertsoylu H, Pehlivan B, Selek U, Topkan E. The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. J Oncol 2020;2020:8832145. [PMID: 33381177 DOI: 10.1155/2020/8832145] [Reference Citation Analysis]
17 Sun Y, Li W, Li AJ, Su H, Yue J, Yu J. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients. Cancer Manag Res 2019;11:3153-62. [PMID: 31114357 DOI: 10.2147/CMAR.S190335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
18 Zhang MH, Wang H, Wang HG, Wen X, Yang XZ. Effective immune-inflammation index for ulcerative colitis and activity assessments. World J Clin Cases 2021; 9(2): 334-343 [PMID: 33521101 DOI: 10.12998/wjcc.v9.i2.334] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Holub K, Biete A. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients. Clin Transl Oncol 2019;21:836-44. [PMID: 30470994 DOI: 10.1007/s12094-018-1991-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
20 Wang Z, Ruan H, Li L, Wei X, Zhu Y, Wei J, Chen X, He S. Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy. Ups J Med Sci 2021;126. [PMID: 34984097 DOI: 10.48101/ujms.v126.8124] [Reference Citation Analysis]
21 Yazdani HO, Huang H, Tsung A. Autophagy: Dual Response in the Development of Hepatocellular Carcinoma. Cells. 2019;8. [PMID: 30695997 DOI: 10.3390/cells8020091] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
22 Benz E, Wijnant SRA, Trajanoska K, Arinze JT, de Roos EW, de Ridder M, Williams R, van Rooij F, Verhamme KMC, Ikram MA, Stricker BH, Rivadeneira F, Lahousse L, Brusselle GG. Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study. ERJ Open Res 2022;8:00628-2021. [PMID: 35036418 DOI: 10.1183/23120541.00628-2021] [Reference Citation Analysis]
23 Jeon BJ, Tae BS, Choi H, Bae JH, Kim JW, Park HS, Park JY. Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma. Investig Clin Urol 2020;61:51-8. [PMID: 31942463 DOI: 10.4111/icu.2020.61.1.51] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Wu J, Tan W, Chen L, Huang Z, Mai S. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Oncotarget 2018;9:13934-47. [PMID: 29568406 DOI: 10.18632/oncotarget.24172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
25 Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T. Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma. Clin Exp Immunol 2019;197:74-82. [PMID: 30821848 DOI: 10.1111/cei.13283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
26 Mirili C, Yılmaz A, Demirkan S, Bilici M, Basol Tekin S. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. Int J Clin Oncol 2019;24:1301-10. [DOI: 10.1007/s10147-019-01461-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
27 Guo D, Zhang J, Jing W, Liu J, Zhu H, Fu L, Li M, Kong L, Yue J, Yu J. Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer. Future Oncol 2018;14:2643-50. [PMID: 29747545 DOI: 10.2217/fon-2018-0285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
28 Holub K, Busato F, Gouy S, Sun R, Pautier P, Genestie C, Morice P, Leary A, Deutsch E, Haie-Meder C, Biete A, Chargari C. Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy. J Clin Med 2020;9:E1441. [PMID: 32408668 DOI: 10.3390/jcm9051441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Çırakoğlu ÖF, Yılmaz AS. Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients. Clinical and Experimental Hypertension 2021;43:565-71. [DOI: 10.1080/10641963.2021.1916944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bauckneht M, Rebuzzi SE, Signori A, Donegani MI, Murianni V, Miceli A, Borea R, Raffa S, Damassi A, Ponzano M, Catalano F, Martelli V, Marini C, Boccardo F, Morbelli S, Sambuceti G, Fornarini G. The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study. Cancers (Basel) 2020;12:E3213. [PMID: 33142739 DOI: 10.3390/cancers12113213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Kato S, Liberona MF, Cerda-Infante J, Sánchez M, Henríquez J, Bizama C, Bravo ML, Gonzalez P, Gejman R, Brañes J, García K, Ibañez C, Owen GI, Roa JC, Montecinos V, Cuello MA. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer 2018;25:821-36. [PMID: 29848667 DOI: 10.1530/ERC-18-0132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
32 Pointer DT Jr, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, Schell MJ, Hodul PJ, Pimiento JM, Fleming JB, Malafa MP. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer 2020;20:750. [PMID: 32782024 DOI: 10.1186/s12885-020-07182-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Karacan Gölen M, Yilmaz Okuyan D. Is the systemic immune-inflammation index a predictive marker of carotid artery stenosis? Journal of Health Sciences and Medicine 2022;5:652-8. [DOI: 10.32322/jhsm.1052129] [Reference Citation Analysis]
34 Bilge M, Akilli IK, Karaayvaz EB, Yesilova A, Kart Yasar K. Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19. Infect Agent Cancer 2021;16:60. [PMID: 34526045 DOI: 10.1186/s13027-021-00400-4] [Reference Citation Analysis]
35 Mori K, Resch I, Miura N, Laukhtina E, Schuettfort VM, Pradere B, Katayama S, D'Andrea D, Kardoust Parizi M, Abufaraj M, Fukuokaya W, Collà Ruvolo C, Luzzago S, Knipper S, Palumbo C, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Egawa S, Shariat SF. Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Cancer Immunol Immunother 2021;70:2641-50. [PMID: 33591412 DOI: 10.1007/s00262-021-02884-w] [Reference Citation Analysis]
36 Ludwig JM, Haubold J, Bauer S, Richly H, Siveke JT, Wimmer J, Umutlu L, Schaarschmidt BM, Theysohn JM. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiol Oncol 2021;55:347-53. [PMID: 34051707 DOI: 10.2478/raon-2021-0027] [Reference Citation Analysis]
37 Yun S, Yi HJ, Lee DH, Sung JH. Systemic Inflammation Response Index and Systemic Immune-inflammation Index for Predicting the Prognosis of Patients with Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis 2021;30:105861. [PMID: 34034125 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Gur DO, Efe MM, Alpsoy S, Akyüz A, Uslu N, Çelikkol A, Gur O. Índice Imunoinflamatório Sistêmico como Determinante de Carga Aterosclerótica e Pacientes de Alto Risco com Síndromes Coronarianas Agudas. Arquivos Brasileiros de Cardiologia 2022. [DOI: 10.36660/abc.20210416] [Reference Citation Analysis]
39 Précoma DB. A New Risk Predictor in Acute Myocardial Infarction. Is There Still Room for One More? Arq Bras Cardiol 2022;119:23-4. [PMID: 35830098 DOI: 10.36660/abc.20220367] [Reference Citation Analysis]
40 Tsilimigras DI, Moris D, Mehta R, Paredes AZ, Sahara K, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB (Oxford). 2020;22:1667-1674. [PMID: 32265108 DOI: 10.1016/j.hpb.2020.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
41 Hua X, Chen J, Wu Y, Sha J, Han S, Zhu X. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis. World J Surg Oncol 2019;17:177. [PMID: 31677642 DOI: 10.1186/s12957-019-1725-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
42 Ozbeyaz NB, Gokalp G, Algul E, Kilic P, Saricam O, Aydinyilmaz F, Guliyev I. Could Systemic Inflammation in Healthy Individuals With Obesity Indicate Subclinical Atherosclerosis? Angiology 2022;:33197221089375. [PMID: 35477291 DOI: 10.1177/00033197221089375] [Reference Citation Analysis]
43 Huang Y, Gao Y, Wu Y, Lin H. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis. Cancer Cell Int 2020;20:499. [PMID: 33061851 DOI: 10.1186/s12935-020-01590-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
44 Fei Y, Wang X, Zhang H, Huang M, Chen X, Zhang C. Reference intervals of systemic immune-inflammation index, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume to platelet ratio, mean platelet volume and red blood cell distribution width-standard deviation in healthy Han adults in Wuhan region in central China. Scandinavian Journal of Clinical and Laboratory Investigation 2020;80:500-7. [DOI: 10.1080/00365513.2020.1793220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Dong M, Shi Y, Yang J, Zhou Q, Lian Y, Wang D, Ma T, Zhang Y, Mi Y, Gu X, Fan R. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis. Ther Adv Med Oncol 2020;12:1758835920937425. [PMID: 32699557 DOI: 10.1177/1758835920937425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
46 Song H, Jeong MJ, Cha J, Lee JS, Yoo JG, Song MJ, Kim JH, Lee SJ, Lee HN, Yoon JH, Park DC, Kim SI. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer. Int J Med Sci 2021;18:3712-7. [PMID: 34790044 DOI: 10.7150/ijms.64658] [Reference Citation Analysis]
47 Isaksson J, Wennström L, Branden E, Koyi H, Berglund A, Micke P, Mattsson JSM, Willén L, Botling J. Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer. Cancer Treatment and Research Communications 2022;31:100556. [DOI: 10.1016/j.ctarc.2022.100556] [Reference Citation Analysis]
48 Zhang T, Wang J, Wang D, Xu K, Wu L, Wang X, Wang W, Deng L, Liang J, Lv J, Hui Z, Zhou Z, Feng Q, Xiao Z, Chen D, Wang J, Wang L, Bi N. The Time-series Behavior of Systemic Inflammation-immune Status in Predicting Survival of Locally Advanced Non-small Cell Lung Cancer Treated with Chemoradiotherapy. Journal of the National Cancer Center 2021. [DOI: 10.1016/j.jncc.2021.11.003] [Reference Citation Analysis]
49 Keles A, Dagdeviren G, Yucel Celik O, Karatas Sahin E, Obut M, Cayonu Kahraman N, Celen S. Systemic immune-inflammation index to predict placenta accreta spectrum and its histological subtypes. J Obstet Gynaecol Res 2022. [PMID: 35365935 DOI: 10.1111/jog.15254] [Reference Citation Analysis]
50 Gambichler T, Said S, Abu Rached N, Scheel CH, Susok L, Stranzenbach R, Becker JC. Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-03929-y] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Hirahara N, Tajima Y, Matsubara T, Fujii Y, Kaji S, Kawabata Y, Hyakudomi R, Yamamoto T, Uchida Y, Taniura T. Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: a Propensity Score-Matched Analysis. J Gastrointest Surg 2021;25:1124-33. [PMID: 32607856 DOI: 10.1007/s11605-020-04710-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Kopecky J, Kubecek O, Buchler T, Melichar B, Poprach A, Zemanova M, Katolicka J, Kiss I, Hajek J, Studentova H, Spisarova M. Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors. In Vivo 2021;35:2981-90. [PMID: 34410998 DOI: 10.21873/invivo.12593] [Reference Citation Analysis]
53 Shoji F. Clinical impact of the systemic immune-inflammation index in non-small cell lung cancer patients. Ann Transl Med 2020;8:668. [PMID: 32617288 DOI: 10.21037/atm.2020.03.180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Njoku K, Ramchander NC, Wan YL, Barr CE, Crosbie EJ. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis. Gynecol Oncol 2022;164:146-53. [PMID: 34802721 DOI: 10.1016/j.ygyno.2021.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Yang Y, Wu C, Hsu P, Chen S, Huang S, Chan WL, Lin S, Chou C, Chen J, Pan J, Charng M, Chen Y, Wu T, Lu T, Huang P, Cheng H, Huang C, Sung S, Lin Y, Leu H. Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest 2020;50. [DOI: 10.1111/eci.13230] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
56 Hayıroğlu Mİ, Çınar T, Çinier G, Pay L, Yumurtaş AÇ, Tezen O, Eren S, Kolak Z, Çetin T, Çiçek V, Tekkeşin Aİ. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol 2022. [PMID: 34978742 DOI: 10.1111/pace.14436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Teishima J, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S, Matsubara A. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Can Urol Assoc J 2020;14:E582-7. [PMID: 32520703 DOI: 10.5489/cuaj.6413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Qiu Y, Zhang Z, Chen Y. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis. Front Oncol 2021;11:537140. [PMID: 33777726 DOI: 10.3389/fonc.2021.537140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zhang Y, Sun Y, Zhang Q. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int 2020;20:224. [PMID: 32528232 DOI: 10.1186/s12935-020-01308-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Tomita M, Ayabe T, Maeda R, Nakamura K. Comparison of Inflammation-Based Prognostic Scores in Patients undergoing Curative Resection for Non-small Cell Lung Cancer. World J Oncol 2018;9:85-90. [PMID: 29988766 DOI: 10.14740/wjon1097w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
61 Brighi N, Farolfi A, Conteduca V, Gurioli G, Gargiulo S, Gallà V, Schepisi G, Lolli C, Casadei C, De Giorgi U. The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment. Cancers (Basel) 2019;11:E1935. [PMID: 31817109 DOI: 10.3390/cancers11121935] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
62 Aquilani R, Brugnatelli S, Maestri R, Boschi F, Filippi B, Perrone L, Barbieri A, Buonocore D, Dossena M, Verri M. Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State. Curr Oncol 2021;28:3280-96. [PMID: 34449579 DOI: 10.3390/curroncol28050285] [Reference Citation Analysis]
63 Li X, Gu L, Chen Y, Chong Y, Wang X, Guo P, He D. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis. Ann Med 2021;53:1827-38. [PMID: 34647517 DOI: 10.1080/07853890.2021.1991591] [Reference Citation Analysis]
64 Wang Y, Li Y, Chen P, Xu W, Wu Y, Che G. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med 2019;7:433. [PMID: 31700869 DOI: 10.21037/atm.2019.08.116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
65 Zhu J, Lian L, Qin H, Wang WJ, Ren R, Xu MD, Chen K, Duan W, Gong FR, Tao M, Zhi Q, Wu MY, Li W. Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters. Oncol Lett 2019;17:2244-56. [PMID: 30675290 DOI: 10.3892/ol.2018.9858] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
66 Samanidis G, Kanakis M, Perreas K. Does systemic immune-inflammation index predict the short outcomes after an acute type A aortic dissection repair? Promising biomarker for acute aortic syndrome. J Card Surg 2022. [PMID: 35137980 DOI: 10.1111/jocs.16297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, Buonfiglioli F, Vitale G, Ravaioli F, Gitto S, Verucchi G, Lenzi M, Bolondi L, Mazzella G, Brillanti S, Andreone P. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Digestive and Liver Disease 2019;51:681-8. [DOI: 10.1016/j.dld.2018.09.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
68 Topcuoglu MA, Pektezel MY, Yilmaz E, Arsava EM. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility. Angiology 2021;72:279-84. [PMID: 33153275 DOI: 10.1177/0003319720969997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Fang Q, Chen H. Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma. Front Oncol 2020;10:591356. [PMID: 33392087 DOI: 10.3389/fonc.2020.591356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
70 Kato A, Hamada T, Miyake T, Morizane S, Hirai Y, Yamasaki O, Iwatsuki K. Clinical and Laboratory Markers Associated With Relapse in Cutaneous Polyarteritis Nodosa. JAMA Dermatol 2018;154:922-6. [PMID: 29955757 DOI: 10.1001/jamadermatol.2018.1601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
71 Demircan NC, Atcı MM, Demir M, Işık S, Akagündüz B. Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy. Asia Pac J Clin Oncol 2022. [PMID: 35538045 DOI: 10.1111/ajco.13784] [Reference Citation Analysis]
72 Teishima J, Inoue S, Hayashi T, Matsubara A. Current status of prognostic factors in patients with metastatic renal cell carcinoma. Int J Urol. 2019;26:608-617. [PMID: 30959579 DOI: 10.1111/iju.13956] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
73 Oguz EG, Yeter HH, Akcay OF, Besli S, Selen T, Derici U, Sencan I, Ayli MD. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit and mortality in maintenance hemodialysis patients with COVID-19. Hemodial Int 2022. [PMID: 35001488 DOI: 10.1111/hdi.13001] [Reference Citation Analysis]
74 Erdur E, Yildirim OA, Poyraz K, Aslan F, Yıldız F, Kömek H. The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features. Postgrad Med 2021;133:694-700. [PMID: 34030576 DOI: 10.1080/00325481.2021.1934493] [Reference Citation Analysis]
75 Halpern SE, Moris D, Shaw BI, Krischak MK, Olaso DG, Kesseli SJ, Ravindra K, McElroy LM, Barbas AS. The Systemic Immune-Inflammation Index Predicts Clinical Outcomes in Kidney Transplant Recipients. In Vivo 2020;34:3349-60. [PMID: 33144442 DOI: 10.21873/invivo.12173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Li M, Li Z, Wang Z, Yue C, Hu W, Lu H. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis. Clin Exp Med 2022. [PMID: 35022918 DOI: 10.1007/s10238-021-00785-x] [Reference Citation Analysis]
77 Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, Zeh HJ 3rd, Zureikat AH, Boone BA. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Ann Surg Oncol 2020;27:898-906. [PMID: 31792715 DOI: 10.1245/s10434-019-08094-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
78 Diao P, Wu Y, Li J, Zhang W, Huang R, Zhou C, Wang Y, Cheng J. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med 2018;16:365. [PMID: 30563540 DOI: 10.1186/s12967-018-1742-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
79 Ertem AG, Ozen Y, Yuksekkaya B, Akif Erdol M, Erdoğan M, Demirtas K, Karanfil M, Akdi A, Yayla C, Burak Akcay A. Association of the Novel Inflammatory Marker Systemic Immune-Inflammation index and Contrast-Induced Nephropathy in Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis. Angiology. [DOI: 10.1177/00033197211045031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Huang Z, Wu L, Hou Z, Zhang P, Li G, Xie J. Eosinophils and other peripheral blood biomarkers in glioma grading: a preliminary study. BMC Neurol 2019;19:313. [PMID: 31805879 DOI: 10.1186/s12883-019-1549-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
81 Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol 2020;18:197. [PMID: 32767977 DOI: 10.1186/s12957-020-01974-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
82 Sun L, Jin Y, Hu W, Zhang M, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma. Front Oncol 2020;10:554521. [PMID: 33194617 DOI: 10.3389/fonc.2020.554521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Zhang Y, Chen B, Wang L, Wang R, Yang X. Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis. Medicine (Baltimore) 2019;98:e13788. [PMID: 30653090 DOI: 10.1097/MD.0000000000013788] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
84 Tosu AR, Biter Hİ. Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia. Arch Med Sci Atheroscler Dis 2021;6:e152-7. [PMID: 34703943 DOI: 10.5114/amsad.2021.109253] [Reference Citation Analysis]
85 Nissani A, Lev-Ari S, Meirson T, Jacoby E, Asher N, Ben-Betzalel G, Itzhaki O, Shapira-Frommer R, Schachter J, Markel G, Besser MJ. Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy. J Immunother Cancer 2021;9:e001743. [PMID: 33990415 DOI: 10.1136/jitc-2020-001743] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Orgul G, Agbal T, Celen S, Caglar AT. Neuroprotective magnesium sulfate administration increases maternal Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index. Arch Gynecol Obstet 2021;303:1433-7. [PMID: 33222038 DOI: 10.1007/s00404-020-05866-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 . UEG Week 2019 Poster Presentations. United European Gastroenterol J 2019;7:189-1030. [PMID: 32213001 DOI: 10.1177/2050640619854671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
88 Yatabe S, Eto K, Haruki K, Shiba H, Kosuge M, Ohkuma M, Ito D, Takeda Y, Sugano H, Sasaki S, Yanaga K. Signification of Systemic Immune-Inflammation Index for prediction of prognosis after resecting in patients with colorectal cancer. Int J Colorectal Dis 2020;35:1549-55. [DOI: 10.1007/s00384-020-03615-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
89 Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. J Cancer. 2018;9:3295-3302. [PMID: 30271489 DOI: 10.7150/jca.25691] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 15.0] [Reference Citation Analysis]
90 Kopecky J, Kubecek O, Priester P, Vosmikova H, Cermakova E, Kyllarova A. Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34446937 DOI: 10.5507/bp.2021.053] [Reference Citation Analysis]
91 Li J, Shao J, Zhang X, Chen X, Zhao W, Qian H, Cui X, Jiang X. Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer. Gastroenterol Res Pract 2020;2020:8781674. [PMID: 33293949 DOI: 10.1155/2020/8781674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Yi HJ, Sung JH, Lee DH. Systemic Inflammation Response Index and Systemic Immune-Inflammation Index Are Associated with Clinical Outcomes in Patients Treated with Mechanical Thrombectomy for Large Artery Occlusion. World Neurosurg 2021;153:e282-9. [PMID: 34217857 DOI: 10.1016/j.wneu.2021.06.113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Wang J, Hui Z, Men Y, Kang J, Sun X, Deng L, Zhai Y, Wang W, Bi N, Liang J, Lv J, Zhou Z, Feng Q, Xiao Z, Chen D, Wang L, Zhao J. Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung Cancer. Ann Thorac Surg 2019;108:1701-9. [PMID: 31400325 DOI: 10.1016/j.athoracsur.2019.06.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
94 Noguchi G, Nakaigawa N, Umemoto S, Kobayashi K, Shibata Y, Tsutsumi S, Yasui M, Ohtake S, Suzuki T, Osaka K, Muraoka K, Hasumi H, Kondo K, Igarashi Y, Sasada T, Kishida T, Yao M. C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma. Cancer Chemother Pharmacol 2020;86:75-85. [PMID: 32537714 DOI: 10.1007/s00280-020-04088-y] [Reference Citation Analysis]
95 Xie Q, Wang L, Zheng S. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis. Dose Response 2020;18:1559325820931290. [PMID: 32647499 DOI: 10.1177/1559325820931290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Kinoshita T, Goto T. Links between Inflammation and Postoperative Cancer Recurrence. J Clin Med 2021;10:E228. [PMID: 33435255 DOI: 10.3390/jcm10020228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Zan Y, Song W, Wang Y, Shao J, Wang Z, Zhao W, Wu J, Xu W. Nomogram for predicting in-hospital mortality of nonagenarians with community-acquired pneumonia. Geriatr Gerontol Int 2022. [PMID: 35789056 DOI: 10.1111/ggi.14430] [Reference Citation Analysis]
98 Shang J, Han X, Zha H, Tao H, Li X, Yuan F, Chen G, Wang L, Ma J, Hu Y. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade. Front Oncol 2021;11:585271. [PMID: 33718140 DOI: 10.3389/fonc.2021.585271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
99 Ma W, Mao S, Bao M, Wu Y, Guo Y, Liu J, Wang R, Li C, Zhang J, Zhang W, Yao X. Prognostic significance of red cell distribution width in bladder cancer. Transl Androl Urol 2020;9:295-302. [PMID: 32420135 DOI: 10.21037/tau.2020.03.08] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
100 Leijten NM, Bakker P, Spaink HP, den Hertog J, Lemeer S. Thermal Proteome Profiling in Zebrafish Reveals Effects of Napabucasin on Retinoic Acid Metabolism. Mol Cell Proteomics 2021;20:100033. [PMID: 33594990 DOI: 10.1074/mcp.RA120.002273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Zhang Y, Liu X, Xu M, Chen K, Li S, Guan G. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Sci Rep 2020;10:8017. [PMID: 32415197 DOI: 10.1038/s41598-020-64684-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
102 Miklikova S, Minarik G, Sedlackova T, Plava J, Cihova M, Jurisova S, Kalavska K, Karaba M, Benca J, Smolkova B, Mego M. Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer. Cancers (Basel) 2020;12:E1134. [PMID: 32369910 DOI: 10.3390/cancers12051134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
103 Morga R, Dziedzic T, Moskala M, Slowik A, Pera J. Clinical Relevance of Changes in Peripheral Blood Cells After Intracranial Aneurysm Rupture. J Stroke Cerebrovasc Dis 2020;29:105293. [PMID: 32992198 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]